Q2 2026 Aug 14, 2026

Enovix shares dropped 8.3% as investors reacted negatively to cautious outlook signals and margin pressures despite modest revenue growth and initial commercial traction, suggesting the company’s longer path to smartphone commercialization and uncertain near-term profitability weighed on sentiment.

Key takeaways

Revenue came in at the high end of guidance but fell short of inspiring confidence, with only early commercial smart eyewear sales and still-unproven smartphone deployments.
Smartphone qualification remains incomplete, with a critical accelerated cycle life test ongoing and final results not expected until year-end, delaying broader adoption.
Smart eyewear shipments (2,100 batteries) generated first product revenue, but the core volume ramp (19,000 units) is slated for next quarter, underscoring limited current scale.
Defense and industrial pipeline expanded 41% sequentially to $183 million in peak annual production value, yet conversion to revenue remains uncertain.
No clear margin expansion or cost efficiencies highlighted amid rising production scale, implying ongoing margin compression concerns.

Q1 2026 May 15, 2026

Enovix shares fell 13.6% as investors reacted negatively to cautious commentary on commercialization timelines and margin pressures despite progress in customer engagements and manufacturing. The market clearly signaled disappointment with the pace of scale and the lack of clear near-term revenue acceleration.

Key takeaways

Q1 revenue was $7.6 million, driven by Korean military contractors, and grew 49% year-over-year but remains limited in scale.
Non-GAAP gross margin contracted to 26.3%, highlighting ongoing margin pressures in early production stages.
Commercial production commenced for the A1 battery in smart eyewear, with shipments ramping expected through H2, but smartphone qualification remains in early stages with updated testing protocols only recently aligned.
Manufacturing yields improved, with most zones nearing or exceeding 90%, though Zone 1 dicing, a throughput bottleneck, is still being optimized with a hybrid dicing solution under development.
The company emphasized active customer dialogues and a growing pipeline ($130 million) — primarily in drone and industrial markets — but scaled commercial launch timelines remain cautious with broader smartphone commercialization expected in 2027.

Q3 2025 Nov 6, 2025

Enovix Corporation delivered robust growth in Q3 2025, with revenue increasing 85% year-over-year to $8 million and achieving a significant gross profit margin while positioning itself strongly for future advancements in battery technology.

Key takeaways

Revenue of $8 million marks an 85% increase year-over-year, driven by strong demand in defense and industrial sectors.
Achieved a non-GAAP gross profit of $1.7 million, representing a 21% margin, a notable turnaround from the previous year.
Successfully validated the AI-1 smartphone battery as the industry leader in energy density and fast charge capabilities, with key partnerships progressing toward commercialization.
Total cash and marketable securities reached $648 million, empowering strategic initiatives, including funding for Fab2 and expanding manufacturing capabilities.
Significant yield improvements and cost optimizations in production processes give Enovix a substantial competitive edge as it prepares for broader market launches in 2026.

Enovix Corporation Common Stock Earnings Recaps

Keep exploring